Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine

Andrea Orué(Instituto Venezolano de Investigaciones Científicas), Manuel Rieber(Instituto Venezolano de Investigaciones Científicas)

BMC Cancer

November 18, 2016

10.1186/s12885-016-2930-9

Cited by 5

Related Papers

DN‐R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: Role of E‐cadherin

|International Journal of Cancer|2009|11